| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 4.1K | Nov 21, 2024 | Direct | ||
| Aptose Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 3.33K | Feb 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ELTX | Elicio Therapeutics, Inc. | Nov 21, 2024 | 1 | $0 | 4 | Nov 25, 2024 | Director |
| APTO | Aptose Biosciences Inc. | Feb 5, 2024 | 1 | $0 | 4 | Feb 7, 2024 | Director |
| ELTX | Elicio Therapeutics, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Director |
| ELTX | Elicio Therapeutics, Inc. | Jun 1, 2023 | 0 | $0 | 3 | Jun 7, 2023 | Director |
| APTO | Aptose Biosciences Inc. | Jan 19, 2023 | 1 | $0 | 4 | Jan 23, 2023 | Director |
| APTO | Aptose Biosciences Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Director |